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Abstract. Background and aim of the work. Due to the ageing of cancer patients, new approaches that require 
a more active participation in the self-management of cancer treatment at home are needed. Nurses are stra-
tegic in improving the patient’s engagement capability in this regard. Knowing which interventions are more 
effective for the promotion of patient engagement could be useful to improve the effectiveness of the care 
provided. Therefore, this study aims to systematically review nursing interventions or programs that promote 
patient engagement in oncological nursing care and summarizing the main evidence related to their impact 
on relevant clinical and psychosocial outcomes. Method. This is a systematic review and meta-analysis protocol 
based on Cochrane Handbook for the systematic review of interventions. We will search the most important 
electronic databases (PUBMED, CINAHL, EMBASE, SCOPUS, ISI Web of Science, Cochrane library) to 
find out which patient engagement interventions (active adult patient involvement) are implemented in onco-
logical settings and understand what is the effectiveness of these interventions on the outcomes reported in the 
literature. The GRADE methodology will be used to synthetize the evidence. If possible, also a meta-analysis 
will be performed. We registered the study protocol on the PROSPERO database (N° CRD42020146189). 
Discussion and Conclusion. To our knowledge, this is the first systematic review to address this clinical question 
in the field of oncology. This review will offer health professionals indications on the most frequently adopted 
patient engagement interventions and verify their clinical effectiveness. Furthermore, any gaps in the scien-
tific literature will be highlighted. (www.actabiomedica.it)
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Background and aim of the work 
The cancer burden in the forty countries of the 
European Region is expected to increase from around 
3.6 million cases and 1.8 million deaths in 2015 to 4.3 
million cases and 2.3 million deaths in 2035, almost 
entirely due to the ageing and growth of the popu-
lation (1). Further increases are also likely to occur 
with the changing prevalence of exposure to “mod-
ern” risk factors, especially tobacco, alcohol, unhealthy 
diet, obesity, and sedentary lifestyles. The changes will 
not be evenly spread throughout Europe, with vari-
ations that depend on the prevalence of risk factors, 
demographic changes and the level of development of 
the health service screening and therapeutic options, 
among other parameters. 
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In Switzerland, cancer causes 9,000 deaths 
among men and 7,000 among women every year. In 
other words, 30% of the total deaths in men and 23% 
in women are due to cancer. In men, 22% of cancer 
deaths are due to lung cancer, 15% to prostate cancer, 
and 10% to colorectal cancer. In women, breast can-
cer is responsible for 19% of the deaths, lung cancer 
for 15% and colorectal cancer for 10%. In children, 
cancer deaths are mostly due to leukaemia and brain 
tumours(2).
To guarantee health system sustainability there 
is the need to adopt innovative organizational models 
and paradigms of care with a renewed focus on the 
promotion of an effective partnership with patients/
consumers (3,4), which is a predictor of patient adher-
ence and compliance to treatment (5–7).
In this regard, patient engagement in cancer care 
is gaining more and more attention (8,9) and is becom-
ing a requirement for the everyday practices of health 
care organizations to address the aforementioned chal-
lenges (10–13).
Patient engagement has been suggested as a 
strategy to improve the effectiveness and efficiency of 
health care systems. The concept of patient engage-
ment was draw up in the USA about a decade ago. 
This concept was based on the idea that the “individual 
recipient of care” should be actively engaged across 
the planning and delivery phases of the health care 
services. Consequently, patient engagement was soon 
approved by policy makers and health care managers 
(14). Therefore, patients not only need to be “put at the 
centre” of medical actions in terms of consideration of 
their needs and expectations of care, but should also 
be seen as a key stakeholder that actively contributes 
to the successful accomplishment of the health care 
organization’s mission and actions.
Patient engagement involves taking a further 
step towards a truly interactive partnership between 
health care recipients and health care providers, where 
patients are considered as one of the main protagonists 
of the management of the health care process in which 
they are directly involved (14). 
Finally, patient engagement research has shown 
the impact of involving people in their healthcare 
pathway on relevant clinical, psychosocial and eco-
nomic outcomes (15–18).
According to the First Consensus Conference on 
Patient Engagement (10,19), health professionals – 
and in particular nurses – are the key catalysers of a 
patient engagement revolution, since they are in the 
frontline with patients in managing the healthcare 
process (20,21). Putting patients at the centre of the 
care pathway is a key element of the nurses’ profes-
sional values and scientific research, therefore nurses 
play a strategic role in promoting patient engagement 
(22–24).
However, to the best of our knowledge, no litera-
ture reviews have been conducted to date on nurses’ 
interventions aimed at promoting patient engage-
ment in oncology settings. The purpose of this study 
is to systematically review nursing interventions or 
programs aimed at promoting patient engagement in 
cancer nursing care and at mapping the main evidence 
regarding their impact on relevant clinical and psycho-
social outcomes. 
Research questions
1.  What nursing engagement interventions (active 
adult patient involvement) have been implemented 
in oncology settings?
2.  What clinical and psychosocial outcomes related to 
these interventions have been described till now?
3.  What is the effectiveness of these interventions on 
the outcomes considered?
Methods
This is a systematic review protocol and it was 
drafted according to the Preferred Reporting Items 
for Systematic Review and meta-analysis proto-
cols (PRISMA-P) check-list (25). We registered the 
review protocol in the PROSPERO database (Regis-
tration number: CRD42020146189).
PICOS
•	 P:  Cancer Patients In General (No Specific 
Diagnosis)
•	 I:  Nursing Engagement Interventions
•	 C:  Routine Care
•	 O:  Improvement of Clinical and Psychosocial 
Outcomes 
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•	 S:  Randomized Controlled Trials, Quasi 
Experimental Studies (Non-Randomized 
Controlled Trials)
Study inclusion and exclusion criteria
All studies considering nursing interventions for 
the promotion of patient engagement in oncology 
settings shall be included. To increase the likelihood 
of retrieving papers related to the research questions, 
studies reporting concepts similar to patient engage-
ment (i.e. patient empowerment, patient activation, 
patient involvement, patient participation) shall be 
included.
We shall try to identify the principal outcomes of 
patient engagement described in the literature to date, 
in the field of clinical oncology nursing, to draw a map 
and evaluate their impact from a clinical and psycho-
social point of view.
With regard to the designs of the included stud-
ies, since our purpose is to provide an answer to a 
therapeutic question, we shall include Randomized 
Controlled Trials. To gain a more comprehensive 
understanding of what has been studied till now, also 
non-randomized controlled trials will be included, 
based on the Cochrane manual for systematic reviews 
(26). 
The type of cancer diagnosis will not be an ele-
ment of exclusion and all studies involving cancer 
patients shall be included. We shall include articles 
written in English, French, Spanish and Italian.
Letters to the editor, case reports, case series, 
comments and other similar types of papers shall not 
be included. Also studies involving children will be 
excluded, given the particular needs of this type of 
population.
Electronic databases
The following electronic databases will be 
searched: PUBMED; CINAHL; EMBASE; SCO-
PUS; ISI Web of Science; Cochrane library.
To retrieve studies not published in peer-reviewed 
journals and avoid publication bias, also grey literature 
will be searched through Google Scholar. 
Search strategy
The following search terms will be used: (“patient 
engagement” OR “consumer engagement” OR 
“patient empowerment” or “consumer empowerment” 
OR “patient activation” or “consumer activation”, OR 
“patient involvement” or “consumer involvement” OR 
“patient participation” OR “consumer participation”) 
AND (nurs* OR “oncology nurs*) AND (neoplasm 
OR tumor OR cancer OR neoplasia OR oncol*). 
Where possible, the electronic database Thesau-
rus and MeSH terms will be used, to refine the string 
of search terms.
The list of references found in the papers will be 
uploaded onto Mendeley to remove duplicates. Two 
researchers will independently search the electronic 
databases and screen the titles and abstracts. Other 
studies will be retrieved by scanning the reference lists 
of the included papers. If necessary, we will contact 
the authors of a paper to obtain any important missing 
information.
The review will be conducted on papers published 
in the last 15 years (2005-2020).
Study selection
The selection of the papers to be included will 
be performed by two researchers independently, by 
reading the title and abstracts. To avoid duplication, 
because of multiple papers derived from the same 
dataset, articles with the same author name, conducted 
in the same context and period, will checked.
The papers that meet the inclusion criteria will be 
evaluated independently by two researchers and the 
decision to include or exclude a paper will be made 
jointly following a discussion.
If no agreement is reached, a third researcher will 
be consulted. The study selection process will be pre-
sented using the PRISMA statement flow chart.
Data extraction
The data of the included studies will be extracted 
by two researchers independently in a systematic way. 
The following data will be extracted from the stud-
ies: name of the first author and date of publication, 
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country where the study was carried out, objective/
research question/hypothesis of the study, method 
used (specifying the study design, the data collection 
process, sample size calculation, if it is a blinded study, 
the process of randomization and recruitment, if the 
authors performed an Intention-to-treat analysis, 
description of the experimental intervention, descrip-
tion of the control intervention, description of the 
outcomes evaluated, main results (both punctual data 
and the 95% confidence interval of the main outcome 
will be reported, if these are available in the included 
studies)), and main conclusions. Data extraction will 
be summarized in a table. 
Quality appraisal of the included studies
The quality of the included studies will be assessed 
independently by two researchers. In case of disagree-
ment a third researcher will be consulted. For the 
quality appraisal of the Randomized Controlled Tri-
als, we will use the revised version of the “Cochrane 
Risk of Bias Tool for Randomized Controlled Trials” 
(RoB 2.0) (27). 
This tool evaluates the range of possible biases of 
RCTs, such as selection bias, concealment bias, selec-
tive reporting, detection bias, and attrition bias. The 
studies can be classified from high to low risk of bias or 
uncertain. We will report the quality assessment of the 
studies in a table to compare all the studies included in 
the systematic review.
For the Non-Randomized Controlled Trials 
(NRCTs) we will use the Cochrane tool Risk Of Bias 
In Non-randomized Studies of Interventions (ROB-
INS-I tool) (28).
Statistical analysis
Tables will be created to summarize the data of the 
included studies and highlight their characteristics in 
the light of the purpose of this review. Following data 
extraction, the research team will evaluate the possibil-
ity of performing also a meta-analysis. Heterogeneity 
across studies will be evaluated using Cochran’s Q and 
Higgins’s I2 statistics. A Chi square < .10 or an I2 > 50% 
will be classified as a high level of heterogeneity.
Synthesis of the results
An integrated analysis of the included studies will 
be performed to assess the impact of patient engage-
ment interventions on the outcomes considered, pro-
viding, if possible, the confidence interval to estimate 
the effect size.
Sensitivity analysis
If possible, a sensitivity analysis will be performed 
to evaluate the influence of each study on the effect of 
the patient engagement intervention in favouring the 
outcomes considered, excluding one study at a time to 
see how the effect changes.
Evidence synthesis
The quality of evidence will be assessed with the 
Grading of Recommendations, Assessment, Develop-
ment and Evaluation (GRADE) system (29), which 
uses a sequential evaluation of the quality of evidence 
and assesses also the cost-benefit ratio, thus determin-
ing the strength of the recommendation.
Validity and reliability
The systematic review will be conducted accord-
ing to the Cochrane Handbook for Systematic 
Reviews of Interventions (26). All the steps of the 
systematic review, such as searching the electronic 
databases, study selection and appraisal, will be con-
ducted independently by two researchers and a third 
researcher will be consulted in case of disagreement. 
The GRADE methodology will be used to synthetize 
the evidence.
Discussion
This study reports the research protocol of a sys-
tematic review aimed at identifying which patient 
engagement nursing interventions are implemented in 
oncology settings, as well as what clinical and / or psy-
chosocial outcomes the interventions have produced 
so far. 
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Moreover, if the studies meet the criteria of qual-
ity and homogeneity, the present revision shall aim to 
investigate – through a meta-analytical approach – the 
effectiveness of the patient engagement interventions.
To the best of our knowledge, this is the first sys-
tematic review that addressed this clinical question in 
the field of oncology.
This review will produce indications regarding the 
most common patient engagement nursing interven-
tions and enable to evaluate their clinical effectiveness. 
Furthermore, any gaps in the scientific literature will 
be highlighted.
Limitations
It is very likely that few Randomized Controlled 
Trials have been conducted to date on this particular 
research question. Therefore, it is possible that not 
much evidence will be available.
Conclusion
To ensure the sustainability of health systems it 
is necessary to adopt innovative organizational care 
models and paradigms with a renewed focus on the 
promotion of an effective partnership with patients/
consumers. Particularly in oncological settings, new 
approaches are needed due to the aging of cancer 
patients, which require a more active participation 
in their health management, and nurses can play a 
key role in improving patient engagement capabil-
ity. Knowing which interventions are more effective 
in promoting patient engagement could be useful to 
improve the quality of care.
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